Abstract
Marginal ulcers (MUs) encompass a group of mucosal disruptions and subsequent inflammatory changes and their sequala found after Roux-en-Y gastric bypass (RYGB) oneanastomosis gastric bypass (OAGB), and, less commonly, after biliopancreatic diversion with duodenal switch (BPD/DS) or single anastomosis duodeno-ileostomy with sleeve gastrectomy (SADI-S). Prevalence of MU after RYGB ranges from .6%–16%. This review summarizes the current knowledge about the treatment options available for MU after MBS for providers who treat them. (Surg Obes Relat Dis 2024;-:1–8.) (c) 2024 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Authors
- R. Wesley Vosburg, MD
- Abdelrahman Nimeri, MD
- Dan Azagury, MD
- Brandon Grover, MD
- Sabrena Noria, MD
- Pavlos Papasavas, MD
- Jonathan Carter, MD